HeartWorks

The HLHS program has formed a nationwide research consortium and developed cell-based therapeutics to treat CHD, some of which are currently in clinical trials. The HLHS program's team of physicians, scientists, and engineers have a combined average of nearly 30 years of experience across their respective disciplines and have focused this expertise... on treatments for the most severe forms of CHD, thereby furthering advanced research in genetics, stem cell biology, clinical trials, and cell-based manufacturing. The team developed a platform that enables multiple cell-based clinical trials to be conducted simultaneously in collaboration with a consortium of world class medical institutions. HeartWorks will expand the HLHS program product pipeline and grow its ecosystem of partners to scale up development of new CHD therapies, clinical trials, and product launches. The company's ecosystem is a critical component of the company's success. All of the company's partners believe in and actively support the company's vision of transformative product development for the CHD community. The company will engender trust with the company's benefactors, CHD children and families, and partner institutions by sharing data and outcomes at a level not possible before within individual institutions. The company will share the company's successes together. Asher -Read More